GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Renalytix RENX.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

5.45p

-0.91%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Renalytix — daily RENX

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Renalytix on TradingView ↗
Market value
£23.8m
Last close × shares
Volume
337.8k
Shares, 9 Nov 2026

About Renalytix

Its shares trade on LSE under the ticker RENX.L. It has been listed since 6 November 2018. In the fiscal year to 30 June 2026, it reported revenue of $3.0m and a net loss of $14.2m. At that date it held total assets of $4.6m and shareholders' equity of −$6.3m.

Renalytix Plc manufactures medical devices and equipment. The firm is focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care. Its diagnostic platform, KidneyIntelX, is designed to scale across kidney disease conditions beyond diabetic kidney disease. KidneyIntelX is a bioprognostic methodology. The firm is evaluating a range of new indications in chronic kidney disease, cardio-renal disease, chronic kidney disease in diverse populations, and coronavirus disease (COVID)-related kidney disease. KidneyIntelX platform facilitates the identification and promotes the effective management of patients at risk of early-stage diabetic kidney disease (DKD), progression by combining diverse data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record (HER) using a proprietary algorithm to generate a unique patient risk score.

Figures and description from our data supplier, not checked against the company's own report.

More about Renalytix →

Latest on Renalytix

Our reporting

We have not reported on Renalytix yet.

Next results

1 Apr 2027

Due on 1 Apr 2027. Analysts expect earnings of -0.05 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Renalytix's ticker?

Renalytix trades as RENX.L on LSE, under ISIN GB00BYWL4Y04.

What was Renalytix's last closing price?

5.45p on 9 Nov 2026. The figure is in GBp and is never converted.

When does Renalytix next report results?

Results are expected on 1 Apr 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.